Amaroq Therapeutics Revenue

Biotechnology Research • Auckland, Auckland, New Zealand • 1-10 Employees

Amaroq Therapeutics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$9,700,000

Key Contact at Amaroq Therapeutics

David Christensen

Director

Company overview

Headquarters	15 Customs St W, Level 22, PwC Tower, Auckland, 1010, NZ
Website	amaroqtx.com
Founded	2021
Employees	1-10
Socials

Amaroq Therapeutics Email Formats

Amaroq Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@amaroqtx.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@amaroqtx.com	100%

About Amaroq Therapeutics

Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer. Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as “dark matter” of the human genome. These naturally occurring molecules do not code for proteins but fulfill important regulatory functions in the cell that could be exploited as a new therapeutic approach for multiple indications. Amaroq’s research team has discovered lncRNA molecules that are highly expressed in cancer cells, and once removed, cancer cell growth slows. Amaroq Therapeutics is developing innovative therapeutics to target lncRNAs for cancer treatment. Amaroq Therapeutics is funded by the Medical Research Commercialisation Fund, managed by life science venture capital firm Brandon Capital Partners, Otago Innovation Ltd, University of Otago, Cure Kids, and NZ Innovation Booster. The Company has been spun out of research from the University of Otago in Dunedin, New Zealand.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

Manager

Employees by Department

Amaroq Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Amaroq Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-08-08	3	$9,700,000

Funding Insights

$9,700,000

Total funding amount

$9,700,000

Most recent funding amount

Number of funding rounds

Amaroq Therapeutics Tech Stack

Discover the technologies and tools that power Amaroq Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Priority Hints

Performance

jQuery

JavaScript libraries

PHP

Programming languages

Flywheel

Hosting

WordPress

Blogs

Divi

Page builders

VentraIP

Hosting

Tachyons

UI frameworks

cdnjs

CDN

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

Amaroq Therapeutics is located in Auckland, Auckland, NZ.

Amaroq Therapeutics generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Amaroq Therapeutics has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Amaroq Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Amaroq Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Amaroq Therapeutics has raised a total of $9,700,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Amaroq Therapeutics

David Christensen

Director

4.8

40,000 users